Le Lézard
Classified in: Health
Subjects: PER, SCZ

Guest Services Appoints Daniel Stoltzfus as Chief Financial Officer


FAIRFAX, Va., July 25, 2019 /PRNewswire/ -- Guest Services, Inc. is pleased to announce the appointment of Daniel Stoltzfus as the Chief Financial Officer (CFO). Stoltzfus joins the Company with nearly 20 years of experience in the business and technology industries.

Stoltzfus has attained diverse skills across different industries, including technology, financial, and entertainment services. Previously, as Chief Financial Officer of Fundation Group LLC, a technology services and specialty finance company, he led a variety of business operational functions and initiated new partnerships for the company's growth. Stoltzfus delivered excellent customer service to public and private companies alike at PricewaterhouseCoopers LLP and led financial and stadium ticket operations during his tenure at the Washington Redskins.

Stoltzfus holds a Bachelors of Business Administration in Accounting from James Madison University.

About Guest Services Inc.
Since 1917, Guest Services, Inc. has earned the reputation of providing the highest quality food, lodging, and leisure services for valued clients and guests throughout the United States. Guest Services offers hospitality management services across a variety of client sites including private and government dining services, national parks, senior living centers, school and university dining facilities, specialty retail stores, and full-service restaurants.

Media Contact
Kat Summers
703-849-9366
[email protected]

SOURCE Guest Services, Inc.


These press releases may also interest you

at 04:28
GymNation, the homegrown UAE fitness brand, has today announced that due to unprecedented growth, it is reaching capacity across its 12 UAE gym locations and diversifying into a new market, brewing up a storm with the launch of its first-ever branded...

at 04:00
Cancer spreads from its primary tumor to other parts of the body via blood or the lymphatic system in a process termed 'metastasis'. This usually represents an advanced stage in the disease's progression and tends to be fatal. Therefore, preventing...

at 03:30
Vicore Pharma Holding (STO:VICO)Sessions at ATS to include an oral late-breaking presentation of the final results from the Phase 2a AIR trial of buloxibutid (C21) in IPFAdditional presentations include preclinical and translational data reflecting...

at 03:13
Orexo's Annual and Sustainability Report for 2023 has been published and can be downloaded at, www.orexo.com. The Swedish version of the Report is also available on the company's website in European Single Electronic Format (ESEF). A PDF version is...

at 03:05
Surge has just closed its second round of funding, raising ?7.5 million. The round was led by Eurazeo with the participation of Kima, Teampact, and MH Innov', as well as the support of historical funds Boutique Venture, HCVC, and 50 Partners Santé....

at 03:00
CSL Vifor is pleased that its partner Akebia Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Vafseo (vadadustat) tablets for the treatment of anemia due to chronic kidney disease (CKD) in adults who...



News published on and distributed by: